These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 10600204)

  • 1. Evaluation of transmission electron microscopy for examination of components of acellular pertussis and combination vaccines.
    Hockley DJ; Williams L; Xing D; Corbel MJ
    Biologicals; 1999 Jun; 27(2):149-54. PubMed ID: 10600204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Composition of acellular pertussis and combination vaccines: a general review.
    Jadhav SS; Gairola S
    Biologicals; 1999 Jun; 27(2):105-10. PubMed ID: 10600195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a guinea pig model to assess interference in the immunogenicity of different components of a combination vaccine comprising diphtheria, tetanus and acellular pertussis (DTaP) vaccine and haemophilus influenzae type b capsular polysaccharide conjugate vaccine.
    Gupta RK; Anderson R; Cecchini D; Rost B; Xu J; Gendreau K; Saroff DL; Marchant C; Siber GR
    Biologicals; 1999 Jun; 27(2):167-76. PubMed ID: 10600208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Verification of components of acellular pertussis vaccines that have been distributed solely, been in routine use for the last two decades and contributed greatly to control of pertussis in Japan.
    Kuno-Sakai H; Kimura M; Watanabe H
    Biologicals; 2004 Mar; 32(1):29-35. PubMed ID: 15026023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactogenicity of infant whole cell pertussis combination vaccine compared with acellular pertussis vaccines with or without simultaneous pneumococcal vaccine in the Netherlands.
    David S; Vermeer-de Bondt PE; van der Maas NA
    Vaccine; 2008 Oct; 26(46):5883-7. PubMed ID: 18775463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approaches to the control of acellular pertussis vaccines.
    Corbel MJ; Xing DK; Bolgiano B; Hockley DJ
    Biologicals; 1999 Jun; 27(2):133-41. PubMed ID: 10600202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WHO working group on standardisation and control of acellular pertussis vaccines--report of a meeting held on 16-17 March 2006, St. Albans, United Kingdom.
    Xing DK; Corbel MJ; Dobbelaer R; Knezevic I
    Vaccine; 2007 Apr; 25(15):2749-57. PubMed ID: 17368348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine.
    Langley JM; Predy G; Guasparini R; Law B; Diaz-Mitoma F; Whitstitt P; Tapiero B; Dionne M; Tomovici A; Mills E; Halperin SA
    Vaccine; 2007 Jan; 25(6):1121-5. PubMed ID: 17045366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplex immunoassay for in vitro characterization of acellular pertussis antigens in combination vaccines.
    Agnolon V; Bruno C; Galletti B; Mori E; Ugozzoli M; Pergola C; O'Hagan DT; Baudner BC
    Vaccine; 2016 Feb; 34(8):1040-6. PubMed ID: 26784684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acellular pertussis vaccines: new preparation. Better tolerated but less active?
    Prescrire Int; 2000 Feb; 9(45):204-7. PubMed ID: 11503797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified intra-cerebral challenge assay for acellular pertussis vaccines: comparisons among whole cell and acellular vaccines.
    Gaines-Das R; Horiuchi Y; Zhang SM; Newland P; Kim Y; Corbel M; Xing D
    Vaccine; 2009 Nov; 27(49):6824-32. PubMed ID: 19765397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardization of acellular pertussis vaccines.
    Kreeftenberg JG
    Biologicals; 1999 Jun; 27(2):115-7. PubMed ID: 10600198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-time polymerase chain reaction detection of Bordetella pertussis DNA in acellular pertussis vaccines.
    Tatti KM; Slade B; Patel M; Messonnier N; Jackson T; Kirkland KB; Talbot EA; Tondella ML
    Pediatr Infect Dis J; 2008 Jan; 27(1):73-4. PubMed ID: 18162945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Laboratory assessment problems of the efficacy of acellular pertussis vaccines].
    Gzyl A
    Przegl Epidemiol; 2004; 58(2):361-7. PubMed ID: 15517817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Verification of components of acellular pertussis vaccines that have been distributed solely, been in routine use for the last two decades and contributed greatly to control of pertussis in Japan.
    Pichichero ME; Decker MD
    Biologicals; 2005 Mar; 33(1):59. PubMed ID: 15713557
    [No Abstract]   [Full Text] [Related]  

  • 17. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
    Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
    Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The immunological basis of the administration of DTP-polio vaccine].
    Cohen H
    Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of serious neurological disorders following immunization: a comparison of whole-cell pertussis and acellular pertussis vaccines.
    Geier DA; Geier MR
    Brain Dev; 2004 Aug; 26(5):296-300. PubMed ID: 15165669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-pertussis components of combination vaccines: problems with potency testing.
    Sesardic D; Dawes CS; Mclellan K; Durrani Z; Yost SE; Corbel MJ
    Biologicals; 1999 Jun; 27(2):177-81. PubMed ID: 10600209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.